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Abstract  
BACKGROUND: Preterm premature rupture of membranes (PPROM) complicates 2 to 3% of 
pregnancies and is associated with significant neonatal mortality and morbidity. Intrauterine 
infection is the most common cause of PPROM, approximately 50% overall. 
 
OBJECTIVES: The primary objective of this study was to evaluate the quality of care delivered 
to women undergoing inpatient management with PPROM compared with a recently instituted 
hospital protocol. A secondary objective was to investigate the maternal and neonatal outcome 
of conservative management of PPROM 24-34 weeks in Tygerberg Hospital (TBH), and to 
determine the impact of the protocol on hospital stay (bed occupancy rate).   
 
METHODS: A prospective population-based observational study on patients with confirmed 
PPROM managed conservatively, between 24 and 34 weeks gestation at TBH from 01 
February 2014 to 31 January 2015. The charts of all patients (n=353) evaluated for possible 
PPROM were retrieved from the online TBH records system, Enterprise Content Management 
(ECM). Ninety-eight patients were eligible for the study. 
 
RESULTS: The cumulative incidence of PPROM in the drainage region during this study period 
was 2.86 per 1000. The median gestational age was at delivery was 31 weeks and 4 days and 
most babies were appropriately grown for their gestation with but with 18 babies born below 
the 10th centile for birth weight according to their gestation. The median birth weight was 1690g. 
The most identifiable associated risk factor was cigarette smoking (35%). In 90% of patients 
with PPROM counselling was not done. Clear nursing prescriptions were not given in 90% of 
patients as per protocol and more than 65% of patients were not given betamethasone at 
correct intervals. Close to 60% of women were given antibiotics correctly and 86% of patients 
were checked for signs of chorioamnionitis twice day as per protocol. Most babies were 
admitted in high care with a median average stay of 8 days, but one stayed a maximum of 188 
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days and 6 babies died from severe prematurity. Other neonatal complications included 
neonatal jaundice (60%), respiratory distress (41%), sepsis (7%), necrotising enterocolitis (3%) 
and patent ductus arteriosus (4%). Total length of stay of mothers in hospital was a median of 
6 days and none of the mothers had complications post-delivery. 
 
CONCLUSION: PPROM is a serious complication of pregnancy and associated with low birth 
weight, preterm delivery significant perinatal morbidity and mortality and prolonged hospital 
stay, however it does not have major impact on maternal outcome as seen in this study. More 
attention needs to be given to provide adequate counselling for women admitted with PPROM 
and train nursing personnel to administer BMZ and antibiotics as prescribed. 
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Opsomming 
AGTERGROND: Voortydse voorkraamse ruptuur van vliese (VVRVV) kompliseer 2-3% van 
alle swangerskappe en veroorsaak betekenisvolle morbiditeit en mortaliteit. Die mees 
algemene oorsaak, in amper 50% van gevalle, is intra-uteriene infeksie.   
 
DOEL: Die hoofdoel van hierdie studie was om die kwaliteit van sorg te evalueer wat 
aangebied is aan vrouens wat toegelaat is met VVRVV. Die standaard waarteen die sorg 
gemeet was, was ‘n protokol vir die hantering van VVRVV wat kort vantevore implementeer is. 
‘n Bykomende doel was om na die uitkoms van moeders en babas te kyk wat konserwatiewe 
hantering vir VVRVV ondergaan het. Daarby was gekyk na die impak wat die protokol op 
bedbesetting het.  
 
METODE: Hierdie was ‘n prospektiewe bevolkings-gebaseerde waarnemingsstudie op 
pasiënte met bevestigde VVRVV tussen 24 en 34 weke wat toegelaat is vir konserwatiewe 
hantering by Tygerberg Hospitaal (TBH). Die tydperk van evaluasie was 01 Februarie 2014 tot 
31 Januarie 2015. Die notas van alle pasiënte met vermoedelike VVRVV was deurgegaan op 
die aanlyn sisteem Enterprise Content Management. Agt-en-negentig vrouens het aan die 
toelatingsvereistes vir die studie voldoen.  
 
RESULTATE: Die insidensie van VVRVV in die hele gesondheidsdistrik was 2.86 per 1000 
tydens die studie periode. Die mediane swangerskapsduur met verlossing was 31 weke en 4 
dae. Meeste babas was toepaslik gegroei vir hulle swangerskapsduur, maar 18 was kleiner as 
verwag (klein vir datums, gedefiniëer as ‘n geboortegewig onder die 10de persentiel). Die 
mediane geboortegewig was 1690g. Die mees algemene faktor wat verband gehou het met 
VVRVV was sigaretrook, in 35% van gevalle. Negentig present van alle vrouens het geen 
raadgewing met toelating ontvang nie. Dieselfde persentasie is toegelaat sonder duidelike 
verpleegvoorskrifte en 65% van vrouens het nie die voorgeskryfde steroïed behandeling op 
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die regte tyd gekry nie. Amper 60% van vrouens het antibiotika op die regte tyd ontvang en  
86% is daagliks ondersoek vir tekens van infeksie. Meeste babas het hoë sorg behandeling 
verkry en die mediane verblyf in die eenheid was 8 dae. Een baba het 188 dae behandeling 
benodig en 6 is oorlede aan erge prematuriteit. Ander komplikasies vir die babas was geelsug 
(60%), asemhalingsnood (41%), infeksie (7%) en nekrotiserende enterokolitis (3%). Die 
mediane verblyf van die moeders was 6 dae en geen van hulle het enige ernstige kompliksies 
gehad nie.  
 
GEVOLGTREKKING: VVRVV is ‘n ernstige komplikasie van swangerskap en hou verband met 
lae geboortegewig, voortydse kraam en betekenisvolle morbiditiet en mortaliteit vir die babas. 
Dis belangrik dat alle vrouens met die probleem goeie raadgewing ontvang met toelating sodat 
hulle bewus is van die omvang van die probleem.  
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1. Background 
1.1 Introduction 
Preterm Premature Rupture of Membranes (PPROM) is an important problem in Obstetrics. 
The consequences can be very serious, as the risk of neonatal morbidity and mortality is very 
high and there is an increased risk of maternal morbidity from infection or sepsis. It is very 
crucial to fully inform patients about the severity of PPROM complications, as the management 
of these morbidities related to PPROM constitute a significant challenge (1).   Infection is the 
main cause of, or result from, PPROM (2).   
1.2 Amniotic fluid and fetal membranes 
The fetal membranes (chorioamnion) are made up of two membranes, the outer chorion and 
inner amnion that enclose the amnion cavity which contains amniotic fluid (AF) (3), both 
derived from the fetal tissue (4).  They are formed during second and third trimester of 
pregnancy. The amnion consists of a single layer of cuboidal cells and collagen. The chorion 
is thicker than the amnion and consists of reticular and trophoblastic cells and is directly 
attached to the maternal decidua (4) .  The strength of the fetal membrane comes from the 
collagen in amnion and the attachment  of these two membranes to each other (5). They have 
a highly protective function against infection and trauma for the growing fetus in utero and also 
promote an environment where amniotic fluid can accumulate, which is important for survival 
of the fetus in utero (5) as it is responsible for fetal development and growth (6). In addition, 
amniotic fluid also protects against infection as it has some bacteriostatic properties, and 
decreased amniotic fluid causes an increased risk of infection (7).  Therefore, it is very 
important for the membranes to remain intact until the onset of labour at term to maintain this 
protective intrauterine fluid environment. 
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1.3 Definitions 
 
Premature rupture of membranes (PROM) is spontaneous rupture of the amniotic 
membrane with a release of amniotic fluid at least one hour before the  labour begins, whereas 
PPROM is prelabour (prior to the onset of labour) rupture of membranes before 37 completed 
weeks  (8)(9)(10). PPROM is divided into three groups : pre-viable PPROM (< 23 weeks),  
PPROM remote from term (from 24 to 32 weeks of gestation), and PPROM near term (32 to 
36 weeks of gestation) (11). 
Latent period – it is defined as the period  between rupture of the membranes and the onset 
of labour (12). Few pregnancies can reach term following PPROM. Approximately 50% deliver 
within one week, 70-75% within 2 weeks and 80- 85% by 28 days following rupture; but the 
degree of latency varies according to the gestational age at the time of rupture of membranes, 
with the labour onset being inversely correlated with gestational age (13). 
 
1.4 Incidence 
 
PPROM complicates 2 to 3% of pregnancies but is associated with 40% of preterm deliveries 
globally, which result in significant neonatal mortality and morbidity (14)(15)(16).  According to 
most studies, the incidence of PPROM varies for different countries and population. This could 
be could be due to the multiple risk factors that are associated with PPROM. According to a 
retrospective study done in Nigeria by Okeke and colleagues over a period of 10 years (1998-
2008), the incidence of PPROM was 3.3% (17). In Southern Africa the incidence varies 
significantly in different populations and figures between 5-40% have been reported (18). 
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1.5 Risk factors for PPROM 
 
Normally, the membranes rupture during labour. There are many risk factors associated with 
PPROM but none of them is known to be directly etiologic. The exact reason for ruopture of 
membranes (ROM) before labour therefor remains unknown. Risk factors include infections, 
cervical incompetence, uterine over-distension as in multiple gestation or polyhydramnios, low 
socio economic status, previous history of PPROM and smoking or vaginal bleeding. (12)(19). 
 
1.5.1 Infection 
 
Intrauterine infection is the most common cause of PPROM, approximately 50% overall (20) 
and thought to be the main risk factor for adverse neonatal outcome, such as cerebral palsy 
(21). About one-third of pregnancies complicated by PPROM will have a positive amniotic fluid 
(AF) culture and it has been shown in studies that bacteria have the potential to cross the intact 
chorioamniotic membrane (15)(22). Most bacteria that are associated with PPROM originate 
from the vagina and cross through the chorioamniotic membranes; then enter the amniotic fluid 
via direct  ascension (20) . 
 
Clinical chorioamnionitis is present in 1-2 % of women with PPROM presenting the first time, 
and subsequently develops in 3-8% of women (22).  Most cases with infection in the AF is 
asymptomatic and do not meet the diagnostic criteria for clinical chorioamnionitis. There are 
certain bacteria that have been demonstrated in microbiologic studies to predispose women 
to PPROM via several mechanisms: Bacteroides species, Trichomonas vaginalis, Neisseria  
gonorrhoea, Group B streptococcus and Chlamydia trachomatis have been associated with an 
increased incidence of PPROM (12). 
 
Stellenbosch University  https://scholar.sun.ac.za
4 
 
Other micro-organisms demonstrated in positive vaginal cultures in women with PPROM were 
Escherichia coli, Gardnerella vaginalis, Proteus vaginalis, staphylococcus species and 
Pseudomonas aeruginosa (23) as well as Ureoplasma urealyticum (24). 
 
1.5.2 Previous PPROM or preterm delivery 
 
Previous PPROM or preterm delivery cause an increase incidence of PPROM in the current 
pregnancy.  Van de Hayden and associates showed an increased recurrence risk of 9% in 
women with PPROM before 27 weeks and  for subsequent pregnancy the risk is about 35% 
(25). 
 
1.5.3 Smoking  
 
The association between smoking and PPROM is controversial, but Andres et al showed no 
difference in the incidence of PPROM when comparing non-smokers to smokers (19). 
 
1.5.4 Iatrogenic causes 
 
Diagnostic procedures such as amniocentesis and chorionic villus sampling increase the risk 
of PPROM. The risk for amniotic fluid leakage following invasive testing is approximately 1-3%  
(5). Procedures such as emergency cervical cerclage in the presence of bulging membranes 
can cause PPROM. 
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1.5.5 Uterine distension  
 
The risk of PPROM is increased in polyhydramnios or multiple pregnancy, as these both cause 
increase pressure on the membrane, stretching it causing weakening of the membranes. 
 
1.5.6 Cervical incompetence and shortening 
 
Cervical length (CL) below 25 mm on transvaginal scan (TVS) (13)(26)  is associated with high 
risk of infection such as chorioamnionitis (27). But, the controversy over the use of TVS to 
predict preterm birth (PTB) and diagnosis of spontaneous preterm labour persists. One  study 
showed that high risk women based on past obstetric history with a CL shorter than 25 mm on 
TVS detected in the early second trimester are at high risk for PTB, whereas those with CL 
below 10 mm with cervical funnelling have increased risk of PPROM (13). A closed internal 
cervical os is unlikely to allow ascending infection as compared to the one that is open. Lee 
and co-workers showed that a short CL (less than 15mm) in PPROM is associated with high 
risk for amniotic inflammation/infection and imminent preterm delivery, independent of the 
existing intra-amniotic inflammation or infection (28). 
 
1.5.7 Dietary habits 
 
Micronutrients deficiencies such as Vitamin C or ascorbic acid have been shown to alter 
collagen structure and this increases the risk of PPROM (29). Others include zinc and vitamin 
E. 
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1.5.8 Other risk factors:  
 
Poor socio economic status, no antenatal care, coitus in the second  half of pregnancy if at risk 
of sexually transmitted disease, abuse of alcohol (18) and occupational factors such as 
strenuous physical work (13) are all associated with PPROM. 
 
1.6 Mechanism or pathogenesis of PPROM 
 
PPROM occurs suddenly and unpredictably. The pathogenesis of PPROM is thought to be 
due to a combination of biochemical weakening of the chorio-amnion (CA) and physical 
stresses. Inflammation of the CA within the AF  plays a major role in the pathogenesis of 
PPROM (3). In normal pregnancy weakening of the membranes occurs close to term (37- 41 
weeks gestation) prior to the onset of labour. The chorion is thicker but very weak as compared 
to the amnion suggesting that biochemical failure of structural components unique to amnion 
may be critical for membrane rupture (3). 
 
Microorganisms produce mucinases and proteases which allow them to break down secretory 
immunoglobulin A and to penetrate the cervical mucosa plug. Thereafter, they release 
collagenases and elastases  (13) that directly damage or weaken the collagen in the 
membrane (12) and a decrease in the collagen content of the membrane increases the risk of 
PPROM (9).  
 
The other theory for the pathogenesis of PPROM is that bacterial invasion of the choriodecidual 
space stimulates the amniotic membrane and decidua to release a number of proinflammatory 
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cytokines including granulocyte colony factor, tumour necrosis factor A and interleukins (-1a; -
1b;-6;-8) (20).  These pro-inflammatory cytokines activate the synthesis of bioactive 
substances like prostaglandins and matrix metalloproteinases (9). The prostaglandins initiate 
cervical changes and uterine contractions, which further weaken the membrane.  The 
metalloproteinases (MMPs) are zinc dependent enzymes capable of degrading extracellular 
matrix macromolecules or their components such as glycoproteins, proteoglycans and 
collagen. These enzymes have been implicated in remodelling as part of both pathological and 
physiological and process (13). Membrane rupture, which is an integral part of human 
parturition, may be either pathological or physiological. Therefore, these enzymes degrade 
connective tissue such as chorioamnion membranes leading to rupture (20) and relax and 
soften the cervix by remodelling the collagen which further leading to membrane rupture (13).  
 
 
Figure 1: Mechanisms of how infection causes PPROM  
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(Adapted from Kavak et al (11)). 
Jeroen and associates showed that weakening of CA  membrane also occurs through 
mechanism of down regulation of amniocyte cytokeratin synthesis, which are components of 
intermediate filaments important for maintaining elasticity, cellular structure, resisting shear 
and this causes the amnion to be vulnerable to shear stress , apoptosis and rupture (3). 
1.7 Diagnosis of PPROM 
 
The diagnosis of PPROM is very important to avoid serious maternal and fetal complications 
associated with it. The diagnosis of PPROM is made on history, physical examination and 
simple side room or laboratory tests. On history, patients may give a history of a sudden gush 
of fluid running down the legs from the vagina followed by uncontrollable leaking. In 90% of 
the time, history of PPROM given by the patient is always correct. The standard tests are 
based on determination of pH or a ferning pattern of salts in amniotic fluid as seen under 
microscopy. These tests are not 100% accurate, they have false positive and false negative 
results. This is due to factors such as scanty residual amniotic fluid in the vaginal vault, 
maternal urinary incontinence and the presence of semen or blood. 
 
1.7.1 Sterile speculum 
 
Digital examination should be avoided as it increases the risk of infection (22) and 
prostaglandin release with the risk of preterm labour, unless there is evidence  that the woman 
might be in active labour (15). The diagnosis of PPROM is easily made when amniotic fluid is 
visualised in the vagina or fluid coming from the cervix on speculum examination. If the fluid is 
present, slight fundal pressure may be applied to facilitate visualisation and collection of fluid, 
and sometimes it is useful to ask the patient to cough or strain down. The fluid is best collected 
from the posterior vaginal fornix at the base of the cervix for laboratory tests (12). 
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1.7.2 Litmus test 
 
It is the most widely used test, and it detects PH changes (15). The litmus test is based upon 
the changes in colour of the litmus paper when exposed to fluids with differing pH values. The 
vaginal pH normally ranges between 4.5 and 6.0 (pink on litmus paper), whereas the amniotic 
fluid has a pH of 6.5 or more (dark blue) (12). The accuracy of the test is approximately 74% 
to 95% (12).  The presence of bacterial vaginosis, urine, semen, soap, cervicitis, alkaline , 
blood and antiseptic solution  may give false positive results (22). To increase accuracy of the 
test, a sample of fluid can be collected from the vaginal pool in the posterior fornix with a sterile 
cotton swab and test the swab with litmus paper (12). 
 
1.7.3 Ferning test 
 
The fern test is accurate 70% to 98% of the time (12). When the amniotic fluid is dried on a 
clean slide and visualised under low (10x) power through a microscope, a characteristic 
arborisation or fern pattern is seen and that is diagnostic for the presence of amniotic fluid. The 
accuracy of the fern test improves markedly with time. Studies have demonstrated that on a 
slide known to have amniotic fluid (from amniocentesis sample), 86% are fern positive at 3 
minutes and 100% are fern positive at 10 minutes (12). Therefore, the false negative rate 
increases with less time or with flame drying (22). False negatives are also possible if the 
patient has had a high (intermittent) leak and is being examined more than two hours after the 
initial episode (12). If results are inconclusive, including the litmus test, the patient needs to be 
placed in a semi Fowler’s position and repeat the speculum examination in 30 minutes. 
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1.7.4 Ultrasound 
 
Ultrasound assessment of the amount of amniotic fluid around the fetus may be useful as 
adjunctive data, but because oligohydramnios can exist as a separate entity, a low amniotic 
fluid volume seen on an ultrasound is not diagnostic for PPROM (12). Theoretically reduced 
or absent (AFI) in a patient with a suspicious history of PPROM could be used as evidence of 
ROM. 
 
1.7.5 Other tests 
 
The diagnosis of PPROM is very difficult after 48 hours or more. In most cases, positive or 
negative results of fern or litmus tests are meaningless (26) . 
 
1.7.5.1 Aspartate Amino Transferase (AST) 
 
Liver enzymes such as AST and Alanine Amino Transferase (ALT) are produced by fetus and 
secreted in amniotic fluid and there is no relation between their amount and that of maternal 
enzymes (26). According to Asgharnia et al, measurement of the AST level in vaginal fluid can 
be used as a reliable test for diagnosis of PPROM. In their study, they showed a significant 
difference between the AST levels of PPROM and that of the normal group, with the sensitivity, 
specificity and positive and negative predictive value of 91, 83, 80 and 93% respectively (26). 
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1.7.5.2 Amnisure ROM and Actim PROM test 
 
These are the non-invasive tests that use a simple dipstick test format to detect specific 
proteins  in the amniotic fluid (30) . The Actim PROM™ (Medix Biochemica) detects insulin-
like growth factor binding protein -1 (IGFBP-1), and Amnisure™ (Qiagen) detects the presence 
of placental alpha macroglobulin-1 (PAMG-1) (31). The IGFBP-1 is synthesised in the fetal 
liver and decidual cells and found in the amniotic fluid throughout pregnancy (30) . A sterile 
polyester swab is used to collect samples for both tests before TVU or vaginal examination 
from vaginal fluid, and then the swab is placed in a buffer containing a solvent, with the lower 
end of the strip submerged (30). The Amnisure™ has been shown to be more accurate in the 
diagnosis of membrane rupture with a specificity and sensitivity of 100% and 98.9% 
respectively (15) (32). According to Ramsauer et al, the PAMG-1 test is more specific and 
sensitive compared to IGFBP-1 (31). 
 
1.7.5.3 Fetal fibronectin (fFN) 
 
Fetal fibronectin is a member of extracellular matrix family and a complex adhesive 
glycoprotein that is found at the maternal fetal interface. It is expressed in the extracellular 
matrix found in the choriodecidual junction between the fetal membranes and maternal 
decidual as well as in the placenta and uterus during pregnancy. It is found towards end of 
second trimester in pregnancy, where it may reflect normal growth of the placenta and 
trophoblasts. It is absent between 22 and 34 weeks gestation, and then is detectable again 
after 34 weeks until term. It is thought to be a trophoblast glue that promotes cellular adhesion 
at uterine-placental and decidual fetal membrane interface. It is released into cervicovaginal 
secretions when the extracellular matrix of the chorionic/decidual interface is disrupted (33), 
due to mechanical factors such as uterine contraction or rupture of membranes (34).  
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According to Goffeng et al, vaginal fFN is a good marker for  fetal membrane rupture (34).  fFN 
is more sensitive and specific than ferning and litmus tests with a sensitivity and specificity of 
94.5 and 89.1 of fFN respectively as compared with 84.5% sensitivity and 78.2% specificity for 
ferning test  and 87.3% sensitivity and 80.9 % specificity for litmus test (33). De Carolis and 
associates showed high fFN levels in the cervicovaginal secretions during the period of 
membrane rupture and subsequently a drop of fFN levels during the period of spontaneous 
resolution of membrane rupture (35). 
 
1.7.5.4 The intra-amniotic injection of indigo carmine dye 
 
This is impractical for routine use and its use remains very limited (31). 
 
1.8 Maternal and fetal complications associated with PPROM 
 
1.8.1 Maternal complications 
1.8.1.1 Infection 
 
The risk of chorioamnionitis is 10 times more for each day a preterm fetus stays in the uterus 
with PPROM (9). The incidence of chorioamnionitis (CAM) when PPROM occurs ranges 
between 5%-10% for those women with latent periods greater 24 hours, compared with a 
general incidence of 1%-2% in women with latent periods less than 24 hours (12). Most studies 
have shown the incidence of CAM to be approximately four times higher in patients with 
PPROM compared to patients without PPROM (9).  The highest incidence of chorioamnionitis 
is associated with prolonged latent period and decreasing gestational age (36). In contrast, 
Stewart et al showed no difference in the incidence of chorioamnionitis related to the latent 
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period (37) . CAM is associated with a high possibility of failed induction of labour resulting in 
caesarean section in patients with PPROM (9)(38). 
 
The diagnosis of chorioamnionitis is clinical and is diagnosed before delivery.  It is considered 
to be a risk factor for increasing rates of neonatal sepsis, premature birth with respiratory 
distress syndrome, perinatal death, cerebral palsy and post-partum maternal infection 
(39)(10)(40)(41).  The diagnosis for clinical CAM requires the presence of fetal tachycardia, 
maternal fever (37.5⁰ C or more), uterine tenderness, maternal tachycardia, foul smelling 
amniotic fluid or maternal leucocytosis (white blood cell (WBC) count of more 15 000/ml3)(39).   
 
There is controversy in the literature regarding the accuracy of the laboratory tests of raised 
C- reactive protein (CRP) and leucocytosis in the prediction of clinical chorioamnionitis with 
ranges from 5% to 47% (14). CRP is known as an inflammatory biomarker that is released in 
response to infection, acute injury or other inflammatory stimuli, but does not specify the 
location or the condition causing inflammation (42). Smith et al failed to show a strong 
correlation between CRP and clinical or histologic CAM, therefore the routine use of CRP level 
as an isolated prediction in the management of patient with PPROM is not recommended (39).   
 
There is not enough evidence to recommend the use of the amniocentesis in diagnosing  
intrauterine infection, however, it is probably beneficial in the 30 to 34 week gestation group 
when knowledge of lung maturity is an important consideration that could influence 
management significantly (12). Amniocentesis has the ability to detect subclinical infection in 
asymptomatic patients- approximately 25% to 30% (positive amniotic fluid culture) in patients 
with PPROM (7)(14) before the onset of clinical  chorioamnionitis  and  fetal sepsis. This may 
allow appropriate  and timeous management such as administration of antibiotics, expectant 
management for patients with negative AF cultures and/or delivery depending on the gestation 
(15).  In addition to culturing the amniotic fluid to identify microbial colonisation, the fluid can 
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also be evaluated for glucose and cytokines such as interleukin 6 and 18, which can indicate 
intrauterine infection (15)(39)(43). 
 
Histologic CAM refers to CAM that is confirmed after delivery by means of histologic evaluation, 
which detects pathogens in usually sterile tissues (39). It occurs in 60% of patient with PPROM 
(6).   
 
1.8.1.2 Abruptio placenta (AP) 
 
The incidence of AP in PPROM ranges between 4%-12%, usually a concealed abruptio 
(9)(36). The cause of placental abruptio in PPROM remains largely speculative. Ananth et al 
showed intrauterine infection as a strong risk factor for placental abruption (44). Secondly, 
oligohydramnios in the presence of PPROM increases the risk of placental abruption and 
thirdly, women with PPROM managed expectantly are at increased risk of developing abruptio 
placenta if the latent period exceeds 24 hours (44).  One of the theories regarding 
pathophysiology of abruptio placenta in PPROM is that acute reduction in the uterine volume 
and intrauterine surface area as a consequence of (preterm) PROM can subsequently lead to 
a disruption of the placental site attached to the decidual spongiosa layer, thereby predisposing 
to AP (44).   
 
1.8.2 Fetal Complications  
PPROM leads to one third of all causes of preterm birth and causes 40-75% neonatal death. 
The fetal and neonatal mortality and morbidity risks are significantly affected by severity of 
oligohydramnios, and gestation at PPROM and duration of latency (45). Lorthe et al found that 
prolonged latency after PPROM does not aggravate neonatal prognosis for a specified 
gestational age at birth (46). Souza et al showed that severe oligohydramnios (AFI <5cm) is 
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associated with high perinatal complications and death (47).  Morbidity and mortality in 
premature infants becomes higher with decreasing gestational age and birth weight. The 
causes of mortality associated with PPROM are discussed below: 
 
1.8.2.1 Pulmonary hypoplasia 
 
Pulmonary hypoplasia occurs most common at PROM less than 29 weeks gestation. It is 
associated with gestational age at the time of rupture of the membranes, oligohydramnios 
during latency and the duration of latency. PPROM that occurs in early gestation is associated 
with increased risk of pulmonary hypoplasia (36). Following a period of prolonged 
oligohydramnios, a proportion of infants develop pulmonary hypoplasia. Their lung to body 
weight ratio and total lung DNA are reduced and the radial alveolar count is decreased and the 
pulmonary vascular bed is reduced in size with a decreased vessel count and increased 
pulmonary vascular muscular development (43).  Persistent oligohydramnios leads to poor 
alveolar development and this becomes evident with failure of lung growth despite prolonged 
latency (45).  
 
Although loss of lung fluid, fetal compression and lack of breathing movements  have all been 
implicated in pulmonary hypoplasia, loss of lung fluid appears to remove the fluid amount 
important for continuing lung development (36).  Reduced amniotic fluid volume is associated 
with increased chest compression, reducing fetal breathing movements and causing an outflow 
(‘squeeze’) of lung fluid from fetus (43). 
 
Even though the use of antenatal steroids and use of exogenous surfactant has markedly 
reduced the mortality and morbidity associated with respiratory distress syndrome (RDS), 
infants suffering from RDS remain at high risk of having increased susceptibility of diseases 
such as respiratory syncytial virus infection and chronic lung diseases (36).   
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1.8.2.2 Intraventricular haemorrhage (IVH) 
 
It causes a significant morbidity in premature infants and is seen in 20% of infants born less 
than 32 weeks gestation. Intraventricular haemorrhage along with central nervous system 
parenchymal echo densities and periventricular leukomalacia increase with decreasing GA 
especially if pregnancy or neonate is associated with other complications. These abnormalities 
are associated with abnormal neurodevelopmental outcome including cerebral palsy. The risk 
of developing cerebral palsy is always increased in prolonged PPROM and CAM 
(36)(45)(14)(16). A significant association between IVH with clinical CAM or placental 
inflammation  has been reported in preterm birth (10). 
 
1.8.2.3 Fetal restriction deformities 
 
In addition to pulmonary hypoplasia, reduced liquor at early gestational age is associated with 
restrictive deformations secondary prolonged compression and lack  of fetal movements (45). 
The deformities include spade like hands and flexion contractions of the elbows, knees and 
feet. This is called the oligohydramnios sequence suggesting that the primary cause is the 
oligohydramnios (36) and the deformities are similar those seen in Potter’s syndrome (45). 
 
1.8.2.4 Cord prolapse 
 
It occurs in 1% to 2% of cases with PPROM but has been reported to occur often in multiple 
gestation- approximately 6% of cases (36). 
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1.8.2.5 Cord compression 
 
It results from both lack of a cushioning effect of the amniotic fluid and prolapsed cord (36). 
 
1.8.3 Complications from labour and delivery 
 
The most common complication is fetal distress and it is usually secondary to other 
complications such as cord compression/prolapse, abruptio placenta and infection. This 
requires emergency caesarean section resulting in low 5-minute Apgar scores in 2% to 20% 
of cases (36). 
 
1.8.3.1 Sepsis 
 
The incidence of sepsis is approximately 1% in the neonates born to mothers with ROM more 
than 24 hours. When clinical CAM is present the risk of proven sepsis increases to 3% - 5%. 
When prolonged ROM is accompanied with prematurity, the incidence of proven sepsis is 4-
6% (45).The risk of neonatal sepsis increases with decreasing gestational age and when 
associated with maternal CAM it has been reported as high as 36% at less than 26 weeks 
gestation.  Escherichia coli and Group B Streptococcus are the most common bacterial causes 
of sepsis associated with PPROM and CAM (36).  
 
1.8.4 Other complications 
 
Other associated complications include necrotising enterocolitis (NEC), Patent Ductus 
Arteriosus (PDA) and prolonged stay in the neonatal intensive care unit post-delivery (48). 
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1.9 Management of PPROM 
 
1.9.1 Use of tocolytic drugs 
 
The use of tocolytic drugs after PPROM remains controversial as PPROM is frequently 
associated with subclinical CAM (11). Tocolysis has not been found to be effective and tocolytic 
drugs have not proved their effectiveness whether in terms of improving perinatal outcome, as 
a prophylactic treatment for onset of labour, or as curative treatment after onset of uterine 
contractions. Currently accepted indications are to allow antenatal corticosteroids to take effect 
or for in utero transfer (49)(50). 
 
1.9.2 Use of corticosteroids 
 
Antenatal corticosteroids have been shown to decrease the risks of respiratory distress 
syndrome, intraventricular haemorrhage, necrotising enterocolitis and as well neonatal death 
in preterm neonates (51)(15)(8). However, Glasner et al showed that steroids impair the 
maternal polymorphonuclear leukocyte (PMN) - based immune system, which is the first line 
of defence mechanism against fungal and bacterial pathogens and in order for host defence 
to be effective, the PMN- based immune system must remain intact. This explains why there 
is still serious prenatal and postnatal bacterial infections of child and mother in spite of antibiotic 
prophylaxis (52). According to a RCOG systematic review and guideline, steroids do not 
increase the risk of infection in either mother or baby (15). 
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1.9.3 Home or outpatient management  
 
The management of PPROM varies depending on the local guidelines, health care setting, the 
opinion of individual clinicians and protocols (53).  Some maternity hospitals offer management 
of PPROM as an outpatient. Planned outpatient management is offered after a period of 
monitoring in hospital with administration of antibiotics and corticosteroids at least for 48 to 72 
hours. Patients considered suitable for outpatient care include: 
• Those living close to the hospital. 
• Access to reliable transportation. 
• No clinical evidence of intrauterine infection or antepartum haemorrhage 
• Absence of contractions and cervical dilatation less than 4 cm. 
 
The advantages of outpatient care may include: 
• Greater convenience for patients and their families 
• Reduced risk of thromboembolic diseases 
• Reduced costs for health care providers 
 
Beckmann and colleagues showed no difference in adverse perinatal and maternal outcomes 
in women who remain undelivered after 72 hours of PPROM either receiving hospital and/or 
outpatient care and did not show that prolonged hospitalisation is associated with a reduction 
in the risk of morbidity for mother and baby (48).  
 
There is not enough evidence to make recommendations for outpatient or home management 
rather than expectant management (EM) in hospital in patients with PPROM. The outpatient 
management for PPROM must be restricted to specific patients  and women should be able to 
take regular temperature recordings at home every day (15). 
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There are two main reasons why outpatient management for PPROM is not recommended, 
namely an increased risk of chorioamnionitis and fetal distress (54). 
 
The management of PPROM is dependent on the GA at the time of rupture of membranes  
(53), and in order to make a decision regarding the management of PPROM, the potential risks 
and benefits of immediate delivery (ID) against EM for each gestational age need to be 
weighed (51). ID would include a planned early birth by either induction of labour or caesarean 
section, while EM would be close monitoring of both fetus and mother till spontaneous labour 
or appearance of a complication that necessitate delivery (51). The main aim for EM is to 
prolong pregnancy and reduce gestational age dependent neonatal morbidity and infections 
(8).  
 
1.9.4 Management options according to gestational age: 
1.9.4.1 Patients with PPROM less than 24 weeks gestation 
 
This is known as previable Premature Prelabour Rupture of Membranes (pPPROM). The 
incidence is less than 1% of all pregnancies but is associated with high perinatal morbidity and 
mortality. In the absence of infection, anhydramnios or fetal anomaly, women who experience 
pPPROM can be offered either termination of pregnancy or expectant management. Azria et 
al showed that perinatal risks after pPPROM remain higher whether women with pPPROM 
choose conservative management or termination of pregnancy (23). Kieffer et al found that 
there is no difference in neurological outcomes at 2 years in the very preterm premature rupture 
of membranes between 14 and 24 weeks gestation compared to those without ROM (26 to 36 
born at similar GA (55). 
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1.9.4.2 Patients with PPROM between 24 and 34 weeks gestation 
 
The first half of the third trimester is particularly troubling because of the competing risks of 
remaining undelivered versus the risks of iatrogenic prematurity following immediate delivery. 
The interventions for PPROM at this stage include the use of steroids, antibiotics, 
amnioinfusion and tocolytics and management can be expectant or planned early delivery(54). 
Expectant management is associated with increased risks of maternal and perinatal infections 
(neonatal sepsis and chorioamnionitis), oligohydramnios (associated with cord compression, 
pulmonary hypoplasia and bronchopulmonary dysplasia) and risk of still birth (placental 
abruption and cord accidents), while on the other hand, immediate delivery poses risks to the 
newborn because of iatrogenic prematurity that also vary across gestational ages (51). Al- 
Mandeel et al found that immediate delivery for PPROM at this gestation has no maternal or 
neonatal benefits (such as decreased risk of maternal infection either antenatal or postpartum) 
compared to expectant management. In fact, immediate delivery is associated with higher risk 
of neonatal deaths and increased the risks of caesarean section by 35% (51) . 
 
1.9.4.2.1 Steroids  
 
Betamethasone (BMZ) is preferred than dexamethasone due to slightly increased risk of 
periventricular leukomalacia associated with dexamethasone in children born prematurely 
(49). According to the RCOG clinical guideline, antenatal corticosteroid therapy in women with 
PPROM is beneficial between 24 to 34 weeks of gestation (15).  
 
1.9.4.2.2 Antibiotics 
 
The use of antibiotics in PPROM between 24 to 34 weeks gestation has been shown to have 
a significant improvement in short term maternal and neonatal morbidity including reduced 
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need for surfactant and oxygen therapy, prolongation of pregnancy, less risk of abnormal 
cerebral ultrasound and reduction in neonatal infection (53)(56)(14)(2). Cousens and 
associates showed that antibiotics for PPROM can reduce death due to  sepsis by 39% and 
reduce complications of prematurity by 12% (2).  The main role of antibiotics in PPROM is to 
prevent ascending infection or treat subclinical infection, thereby improving neonatal outcome 
(56).   
 
The most common causative agents for intrauterine infection in PPROM are anaerobic , 
aerobic and mycoplasmas, thus broad spectrum antibiotics (erythromycin and ampicillin ) are 
more beneficial in  PPROM (8). The Oracle 1 trial showed that erythromycin when compared 
to placebo was associated with a reduction in chronic lung disease (decreased need for 
exogenous surfactant, neonatal ventilation or oxygen), and decreased major cerebral 
abnormalities as well as a reduction in the rate of positive neonatal cultures (14). Even though 
erythromycin the is most frequently used macrolide antibiotic for mycoplasma and bacterial  
infection during pregnancy, it has severe gastrointestinal side effects and poor oral 
bioavailability limit the clinical utility thereof (56). A clinical trial of an antibiotic regimen that 
used clarithromycin (a semi-synthetic macrolide antibiotic) showed that it may be an alternative 
worth considering with potentially beneficial effects compared to erythromycin in PPROM. The 
reasons are its better oral bioavailability, it  is associated with a lesser degree of histological 
funicitis and better tissue penetration (e.g.to placenta) compared to erythromycin (56).  
 
Yeung et al showed that penicillin is the drug of choice to treat group B Streptococcus 
infections, which remains as the most predominant organism causing early onset neonatal 
sepsis (GBS) in active carriers and erythromycin is less effective in treating GBS infections 
(16).  
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The ORACLE 1 trial also found that amoxicillin/clavulanic acid was associated with decreased 
uterine infection compared to erythromycin and placebo, but there was greater number of 
babies with suspected or proven necrotising enterocolitis in the amoxicillin/clavulanic acid 
group than in any no amoxicillin/clavulanic acid group and there wasn’t any harm associated 
with erythromycin (14), therefore the use of amoxicillin/clavulanic acid is not recommended in 
this context. 
 
1.9.4.2.3 Amnioinfusion 
 
PPROM leads to oligohydramnios, thus placing the fetus at risk of umbilical cord 
compression and other complications such as pulmonary hypoplasia. Amnioinfusion has been 
described as a method of preventing such complications (15), but according to the 
PPROMEXIL III trial by van Teeffelen et al there was no evidence to support the use of 
amnioinfusion in the management of PPROM (57). 
 
1.9.4.2.4 Sealing procedure for PPROM 
 
The routine use of sealants is not currently recommended for treatment of second trimester 
oligohydramnios by PPROM due to lack of sufficient evidence to support its success rate and 
safety in a recent systematic review  (5). 
 
1.9.4.3 Patients with PPROM over 34 weeks gestation 
 
The American College of Obstetricians and Gynecologists (ACOG) guidelines recommend 
induction of labour (IOL) for PPROM after 34 weeks gestation. The RCOG guidelines also 
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recommends delivery after 34 weeks gestation but those who are managed expectantly 
beyond 34 weeks should be counselled regarding the  risk of CAM and presumed decreased 
risk of neonatal respiratory complications, admission for neonatal intensive care and 
caesarean section (58). According to the PPROMEXIL II trial, van de Ham and associates 
showed that for pregnancies complicated by PPROM after 34 weeks of gestation, IOL does 
not reduce the incidence of neonatal sepsis nor did it influence the rates of caesarean section 
and respiratory distress compared to expectant management. However, IOL increased the risk 
of hyperbilirubinemia, hypoglycaemia  and  the use of epidural analgesia during labour (59). 
 
An evidence based clinical protocol was developed and implemented in 2012 at Tygerberg 
Hospital for investigation and management of PPROM, based on the best available 
international guidelines and evidence from randomised controlled trials (60). Gaps often exists 
between clinical guidelines and the eventual clinical practice (61), therefore the development 
of a specific protocol or tool that specifies exact steps and actions to be taken can assist in 
guideline implementation (62). However, there may be large gaps between the known effective 
practices and what is actually done in real life and in clinical practice often performed under 
less than ideal circumstances (63).  
 
Fidelity in research refers to the extent that the study team complies with the study protocol 
and is different to adherence, which refers to the behaviours of the participants (64). 
Implementation (or intervention) fidelity can be described as the degree to which a specific 
intervention is delivered as prescribed or intended during clinical practice (65). The same 
principles apply to interventions aimed at improving clinical care and any clinical protocol will 
only be as effective as the clinical personnel administering the critical steps. There are not 
many examples of intervention fidelity in clinical practice neither does a literature search readily 
identify tools or models that can be used.  
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The method employed in this study was to evaluate each component of the protocol based on 
written evidence in the clinical notes. For each component, a dichotomous question was 
developed to provide a Yes/No answer. This is further described in the methods section.  
 
The two cardinal questions that arise with this type of intervention research is whether the 
intervention is applied as prescribed and whether it makes a difference to clinical outcome. 
The latter can only be measured when there is a control group without the specific intervention 
(or historical pre-protocol outcome data is available). Very large sample sizes will be needed 
to measure any difference in clinical outcome. But the evidence and comparative studies are 
already available and distilled into a protocol. The implementation part is more related to the 
external validity of all the guidelines. The intention is therefore not to measure the impact of 
the protocol on clinical outcome, but to focus on the correct implementation and ways of 
improving the care. This in turn may improve the quality of care delivered to women with 
PPROM. 
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2. Objective and aims 
2.1 Objective 
• The objective of this study was to evaluate the quality of care delivered to women 
undergoing inpatient management with PPROM by measuring intervention fidelity to a 
recently instituted hospital protocol.  
 
 
2.2 Aims 
• To describe the characteristics of women admitted for conservative management of 
PPROM. 
• To describe the practices of the clinical personnel during management of women with 
PPROM during the pre-admission phase as well as during the in-patient period. 
• To measure intervention fidelity to the new protocol. 
• To determine the impact of the protocol on hospital stay (bed occupancy rate).   
• To determine pregnancy outcome and PPROM-linked mortality. 
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3. Methods 
3.1 Study design 
This was a prospective population-based observational study. 
 
3.2 Setting and study population 
The study group were all women between 24 and 34 weeks of gestation, admitted for 
conservative management of confirmed PPROM between 1 February 2014 and 31 January 
2015. Tygerberg hospital is a referral hospital for all women with complications requiring 
specialist attention. The greater catchment (referral) area is a geographic health district in 
Cape Town called Metro East (consisting of 14 sub-councils) with a population of 2 416 560 
(2011 census). Within Metro East there are 3 large district hospitals and 8 midwife obstetric 
units (MOU) that refer women to Tygerberg according to a standardised protocol. This 
regionalisation of care is driven by a set of protocols and care is standardised across the 
platform. 
 
The PPROM protocol was workshopped with all clinicians before implementation and was 
readily available (printed copies in all clinical areas and electronic version on the departmental 
website). A copy of the protocol is attached as Appendix I.  
 
3.3 Inclusion criteria 
The diagnosis of rupture of membranes was made on clinical grounds as per hospital protocol 
by a combination of convincing history and confirmed by speculum examination (pooling of 
liquor in the posterior fornix). When the diagnosis was doubtful, pH changes in vaginal fluid 
was determined using litmus paper and fluid was examined under a microscope for ferning. If 
still doubtful, women were admitted for sanitary pad check for 24 hours followed by amniotic 
fluid determination on ultrasound (amniotic fluid index >5 or deepest pool >3 cm regarded as 
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normal). If pads were dry and amniotic fluid volume normal, they were discharged and not 
entered into the cohort. Conservative management (inpatient treatment) included bed rest, 
antibiotic and corticosteroid administration, tocolysis if in labour before steroid maturity (within 
48 hours after PPROM). Women remained in hospital until 34 weeks or spontaneous onset of 
labour. If not delivered by 34 weeks, they were induced according to standard protocols for 
induction of labour. 
 
3.4 Exclusion criteria  
Women who were in active labour on presentation, multiple pregnancies, clinical signs of 
chorio-amnionitis, fetal compromise, cord prolapse, fetal death, gestation >34 weeks and 
women who declined conservative management of PPROM were excluded. Clinicians 
managing women were not aware of the audit.  
 
3.5 Measurement of intervention fidelity 
A set of 23 questions were developed to measure fidelity to each of the 23 critical components 
of the protocol. Overall mean fidelity to the protocol was calculated as the number of 
interventions fulfilled/23 (the total number of interventions recorded). There were 15 
interventions related to pre-admission selection and 8 related to conservative management as 
inpatient. The tool is available as Appendix II. 
 
3.6 Data collection  
Data collection was done retrospectively, after discharge of the baby from the hospital, to 
minimise observer effects. The charts of all patients (n=353) were retrieved from the online 
TBH records system, Enterprise Content Management (ECM) and data extracted by the 
principal investigator. Baseline delivery data was obtained from routinely collected hospital and 
regional data. 
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The following maternal characteristics were collected: date of first antenatal visit, level of care, 
maternal age. For obstetric history, data were collected on gravidity and parity, previous 
surgery on the genital tract or uterus including caesarean section and cervical cerclage, 
previous preterm labour or PPROM and current obstetric history. The medical history, pre-
pregnancy body mass index (BMI), HIV, syphilis, rhesus status and lifestyle factors (smoking, 
alcohol, recreational drugs) were obtained from the first antenatal visit notes. 
 
Clinical data on the date admitted with PPROM, confirmatory tests for SROM, maternal vital 
signs on admission, urine analysis, haemoglobin value, uterine activity, ultrasound on 
admission and indication for ultrasound, baseline fetal monitoring (cardiotocography CTG) and 
midstream urine culture and sensitivity were obtained from the clinical notes and laboratory 
reports. The prescription chart and nursing notes was analysed to obtain data regarding 
nursing instructions, antibiotic prescription, daily fetal movement monitoring and CTG, 
corticosteroids, tocolysis and any other drugs or agents.  
 
The clinical notes were used to assess documentation of counselling, date patient discharged 
from protocol and reason and any complications arising during the hospital stay. The hospital 
patient information system was used to determine length of stay in hospital for mother and 
baby. The delivery report was used to obtain data on the mode of delivery, method of delivery, 
maternal complications during delivery and the date of delivery. The neonatal folder was 
analysed for birth weight, Apgar scores (1 and 5 minutes), outcome of baby and any 
complications. Maternal mortality was defined as any maternal death during pregnancy or 
within 42 days after delivery; a neonatal death as any death occurring after delivery and before 
7 days of life and stillbirth any death after 22 weeks but before delivery.  
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3.7 Data analysis plan 
Demographic, clinical and outcome data were entered in an Excel spread sheet. Patient 
identity was delinked from the data sheet and sequential numbers were allocated to individual 
patients. Data analysis was done using STATA 14 (StataCorp LP, USA). 
 
3.8 Ethical considerations 
Consent to perform the study was obtained from the Health and Research Ethics Committee 
of Stellenbosch University as part of a larger study into patient outcomes at Tygerberg Hospital 
(S12/09/240). A waiver of patient consent was obtained as data was collected retrospectively, 
after discharge of the patient.  
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4. Results 
There were 34 948 deliveries during the study period in the metro east geographical region 
with a population-based caesarean section rate of 26.3%. Of these, 721 were stillbirths; 285 
in the 500-999g birthweight group and 436 weighed 1000g or more. Of the 34 227 live births, 
149 babies died within 7 days of birth and 35 were late neonatal deaths. PPROM was the 
primary (obstetric) cause of death in 1.7% of perinatal deaths in the population. Only 5 of these 
deaths were reported outside of Tygerberg hospital (all stillbirths). Tygerberg is the only referral 
hospital for women with ROM prior to 34 weeks where conservative management is 
appropriate. On evidence of this data, it can be assumed that most women with PPROM would 
have been referred and managed appropriately at Tygerberg hospital and included in this 
survey. 
 
Of all the deliveries in Metro East, 8436 delivered at Tygerberg hospital with a CS rate of 
47.35%. There were 419 multiple pregnancies. During the study period 353 women were 
referred to Tygerberg for suspected PPROM. After excluding those who delivered on arrival 
and those without evidence of PPROM, n=98 women qualified for conservative management. 
The cumulative incidence of PPROM during this study period was 2.86 per 1000 deliveries. 
The syphilis prevalence amongst perinatal deaths was 10/1000. 
 
The baseline demographic and clinical characteristics of the participants are shown in Table I. 
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Table 1- Baseline demographic characteristics 
 Number Percentage 
Age   
<19 years 17 17,3 
19-37 years 75 76,5 
>37 years 6 6,1 
Racial ethnic group   
African 56 57,1 
Mixed ancestry 42 42,9 
Gravidity   
1 31 31,6 
2-5 60 61,2 
>5 7 7,1 
Parity   
0 34 34,7 
1-5 60 61,2 
>5 4 4,1 
Body Mass Index (BMI)   
<18.5 (underweight) 5 5,1 
18,5-24,9 (normal weight) 45 45,9 
25-29,9 (obese) 23 23,5 
>30 (morbidly obese) 25 25,5 
 
The mean age on admission was 26.3 years (range 17-42 years) with most patients in the 19-
37-year-old group. The mean BMI was 27.4 kg/m2 with a range of 17.1-47.7 kg/m2. Almost half 
(49%) of all women admitted were in the obese (BMI ≥25 kg/m2) category. 
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The lifestyle habits of the patients are shown in Figure 2. More than 35% of the women were 
smoking during the pregnancy. Drugs and circumstance refer to the abuse of any illicit drugs. 
Figure 2- Lifestyle habits of the women admitted to the study. 
  
The method of diagnosing SROM is shown in Figure 3. In most women the diagnosis was 
made with a pH change in the vaginal fluid using Litmus paper (almost 60%). 
Figure 3. Method of diagnosis of SROM. 
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Tocolysis was indicated in 33 (34.5%) in women. The agents used for tocolysis are shown in 
Figure 4  
Figure 4. Agents used for tocolysis when indicated. 
  
Eighteen percent of women had a previous history of miscarriage and 11% a history of previous 
preterm labour. This is shown in Figure 5. 
Figure 5. Previous obstetric history. 
 
 
About 18% of women had previous miscarriage and only 11% had previous preterm labour. 
 
76%
3%
18%
3%
Agent used for tocolysis
Nifedipine Indomethacin Combination Not prescribed
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The current obstetric history is shown in Figure 6. More than 20% of women already had 
symptoms or signs of preterm labour earlier in the index pregnancy. 
Figure 6. Current obstetric history. 
  
Most women (almost 80%) were healthy at the time of entry to the study. This is shown in 
Figure 7.  
Figure 7. Medical history of women admitted with PPROM. 
  
 
Stellenbosch University  https://scholar.sun.ac.za
36 
 
Most women went into spontaneous labour before 34 completed weeks. The reason for 
discharge from the protocol is shown in Figure 8. Less than 15% reached 34 weeks with 
conservative management. 
Figure 8. Reasons for discharge from the protocol. 
  
The mode of delivery is shown in Figure 8. Twenty-six percent of women were delivered by 
caesarean section. 
Figure 9. Mode of eventual delivery. 
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Half of all the Caesarean sections were for some form of fetal compromise during labour. 
Fourteen percent of caesarean sections were done for undiagnosed breech. This is shown in 
Figure 10. 
 
Figure 10: Indications for caesarean section 
  
 
The mean pre-admission fidelity to protocol was 51.3% and the mean inpatient fidelity was 
45.8%, which was not significantly less (p=0.43). Overall, fidelity to all facets of the intervention 
protocol was less than 50%. This is shown in Figure 11. 
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Figure 11. Overall protocol fidelity as measured by the audit. 
 
 
In more than 90% of women, no adequate counselling was documented. Clear nursing 
prescriptions were not given in 90% of patients as per protocol. More than 65% of patients 
were not given BMZ correctly. Close to 60% of women were given antibiotics correctly. About 
86% of women were checked for signs of chorioamnionitis twice a day.  
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Maternal outcomes: 
None of the women had any severe maternal complications during the antenatal stay or 
delivery. 
Most babies were admitted to High care. There were 5 ICU admissions and 6 deaths. This is 
shown in Figure 12. 
Figure 12. Neonatal outcome. 
  
 
Birthweights according to the accurate gestation (based on early ultrasound where available) 
were plotted on a chart using the 90th, 10th and 3rd centiles for growth according to the 
INTERGROWTH (66) standards, which is in use at Tygerberg Hospital as the preferred 
standard to assess for small-for-gestational age babies (SGA). There were 18 SGA babies in 
the cohort, of which 10 was severely small (below the 3rd centile). This is shown graphically in 
Figure 13, with weight on the Y axis and gestation on the X axis and the centiles shown as P3, 
P10 and P90.  The median birth weight was 1690g (range 750g-2990g). The median gestation 
at delivery was 31 weeks and 4 days (range 24 weeks 5 days to 35 weeks 1 day).  
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Figure 13. Birth weight according to gestation at delivery. 
 
 
Women stayed a median of 4 days on the protocol (admission to delivery) with a range of 0-
29 days. The total length of stay of mothers (from admission to discharge from hospital) was 
a median of 6 days (ranging from 1- 63 days) and most these mothers stayed in hospital post-
delivery due to their babies admitted either in ICU or high care. Seven of the women refused 
hospital management and 6 of them came back in spontaneous labour and had normal vaginal 
delivery with no maternal complications and the babies stayed a maximum of 6 days in hospital 
with good outcomes; 1 case had an elective repeat CS. 
 
Babies were admitted for a median of 8 days after delivery (range 0 to 188 days). There were 
6 babies who died, mostly from severe prematurity. Sixteen babies had a low 1-minute Apgar 
score of <7 and six of them died and 10 of these babies had a prolonged stay in hospital. Sixty 
babies suffered from neonatal jaundice. Fourty-one babies had HMD/RDS. Seven babies had 
severe sepsis and two of them died from other complications of prematurity.  
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Only three babies had NEC. They were all below the gestation of 30 weeks. Two of them were 
given BMZ correctly and one of them BMZ was given 18 hours apart instead of 24 hours. 
Seven babies had feeding intolerance and 6 of them had a prolonged stay in hospital and all 
had a weight of below 1200g. Four babies suffered from PDA and two of them were admitted 
in ICU and had a prolonged stay (100 and 72 days, born at 28w4d and 31w 2d respectively). 
The other 2 were admitted in High care (37 and 27 days, born at 30w0d and 29w1d 
respectively). 
 
Regarding the six neonatal deaths, there were 3 unexplained intrauterine deaths with no clear 
evidence of clinical chorioamnionitis or abruptio placenta; the other 3 were neonatal death after 
15, 25 and 50 days in hospital post-delivery. These were associated with complications of 
prematurity.  
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5. Discussion 
Although the sample is small, the results of this retrospective audit enabled an assessment of 
the actual inpatient management of PPROM at Tygerberg Hospital to see if this complied with 
the recommended protocol for PPROM that was implemented in 2012. In terms of clinical data 
and outcomes, the first striking finding is that most cases of PPROM occurred in women 
without a previous history of preterm labour or PPROM. They were also healthy with no 
underlying medical condition. The implication is that these women will be attending antenatal 
care at community clinics and it is important that basic antenatal care providers are regularly 
updated on the diagnosis and correct initial management before referral. Nimrodi and 
colleagues investigated a hypothesis in a similar group of low risk women, speculating that 
pre-existing cervical inflammation may lead to PPROM; however in this population-based 
cohort there was no difference in clinical outcome in the group with inflammation and the group 
without (67). Until there is an easily identifiable risk factor for PPROM, routine care will have 
to include information on this specific danger sign of pregnancy.  
 
It is important to note that in many women there were a prior alert in the current pregnancy 
(mostly a prior episode of preterm labour). These women therefor need to stay at a more 
specialised level of antenatal care and be well informed. A randomised trial from India in a 
similar low-risk population showed that routine cervical length screening did not reduce the risk 
of pre-term labour, therefore increase clinical vigilance remains the only current standard of 
care (68).  
 
More than half of women in the study were obese; this is a known risk factor for PPROM and 
in the Metro East regionalised perinatal care system a BMI of >40kg/m2 is a reason for referral 
for specialist care. A recent study showed that even amongst women managed conservatively 
for PPROM, maternal obesity was an independent risk factor for chorioamnionitis with a hazard 
ratio of HR 1.6  (95%CI 1.1–2.1, p =  0.008) (69). Future protocols of conservative management 
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of PPROM may include earlier elective delivery for obese women and this is an area that needs 
further research in the TBH population.  
 
The study results regarding neonatal outcomes (complications of prematurity and prolonged 
hospital stay) is consistent with what has been found in the literature as summarised in the 
introduction. Although infection is a major trigger for PPROM, sepsis is also the most important 
cause of morbidity in the premature infant and therefor premature deliveries in women with 
PPROM should be avoided to decrease prematurity related outcomes. This is also the 
conclusion of a recent study to assess the predictors of outcome in terms of length of stay and 
survival of neonates from women with PPROM (70). Even this may be difficult, as only 15% of 
women made it to 34 weeks in the current study. 
 
It is surprising that 14% of CS were done for undiagnosed breech presentation in labour. These 
are patients managed in a setting where they should receive daily abdominal examinations for 
signs of infection. Health care workers should be reminded to note the presentation at the daily 
examination and be prepared for management of a breech presentation and the associated 
risks (including cord prolapse). 
 
The main reason for Caesarean delivery was fetal distress. Babies from mothers with PPROM 
are already compromised babies at risk for antepartum and intrapartum fetal heart rate 
abnormalities, so this was not an unexpected finding. Davis and colleagues investigated 
continuous fetal monitoring for PPROM before the onset of labour and found that abnormal 
heart rate tracings are already present in a significant percentage of women (71). The current 
hospital protocol recommends only one CTG per day and the importance (and feasibility) of a 
more frequent schedule needs to be investigated. A study measuring fidelity to a protocol of 
continuous fetal monitoring in women with PPROM found that a significant proportion (28.3%) 
of CTGs were not recorded as ordered (72). Fetal monitoring can also predict histological 
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chorioamnionitis- a study from France showed that decreased variation in the fetal heart rate 
pattern was associated with chorioamnionitis, especially in the last 24 hours before delivery 
(73).  
 
Although most babies were appropriately grown for their gestation, 18 babies were smaller 
than the 10th centile for birth weight according to their accurate gestation. These findings were 
not detected before delivery, and a special effort should be made to diagnose the SGA babies 
in the PPROM cohort. They are more at risk- SGA babies mothers with PPROM has an 
increased risk for severe neonatal morbidity, early childhood death and moderate or severe 
cerebral palsy (74). Since the study was done, a new protocol for management of SGA babies 
was introduced at Tygerberg Hospital. A large population-based study in women with PPROM 
found that the risk of cognitive impairment during childhood was greatest when the period 
between rupture and delivery was less than three days (75). This is an important finding, as 
the median number of days gained in the current study was only 4 days. 
 
In terms of quality of care, the lack of adequate counselling (as documented in the folder) in 
90% of patients admitted with PPROM is a cause of concern. It is the responsibility of the 
admitting and treating health car practitioner to counsel parents about PPROM as it is 
associated with poor adverse perinatal outcomes and prolonged stay for both mother and 
baby. There is therefore a need to educate health care providers in the facility on the multiple 
management options and interventions and to enhance communication skills. A program of 
training and monitoring of providers ensure implementation fidelity in clinical trials in other 
settings and that knowledge can be used to ensure fidelity in this hospital setting as well (76). 
A simple patient information leaflet can also be developed to assist with information. In the 
literature, barriers to implementation fidelity include time constraints in daily practice, difficulties 
with patient selection and incompleteness of medical files (77). 
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The tool developed here can be used (or adapted for other clinical scenarios) for any quick 
survey of the quality of care delivered to a specific patient group. The tool is available as an 
Excel document that generates the findings automatically in descending order of importance 
as answered. There is a growing body of evidence on fidelity scales and performance 
measures as tools to support quality assurance in a variety of health care settings (78). It may 
also be better to focus on a tool design that explore and explain variation in implementation 
fidelity rather than aiming to control for that variation (79). 
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6. Conclusion 
Based on the data and discussion presented here, the management protocol can be updated 
to include the clinical aspects that was identified during the audit (including the clinical 
importance of obesity, checking the presentation daily to exclude undiagnosed breech, and 
careful assessment and more frequent fetal heart rate tracings).  
 
A further recommendation is that the data obtained from this study be used to develop a patient 
counselling and information leaflet. Important factors to include will be the signs and symptoms 
of infection, the risk for premature delivery, and the 26% risk for CS, the prolonged hospital 
stay for both mother and baby and the risk of adverse outcome of the baby. 
 
Regarding intervention fidelity, the tool is now available for use and can be refined and adapted 
to monitor implementation of the recommendations from this study and the effect this has on 
clinical care and quality of care.  
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Items related to initial admission  Yes No Not indicated 
1 Was a clear history documented?    
2 Was gestation calculated correctly?    
3 Were maternal vital signs documented?    
4 Was urine disptix documented?    
5 Was hydration status documented?    
6 Was uterine activity documented?    
7 Was ultrasound performed at admission?    
8 Was baseline CTG documented? (Not indicated if fetus not viable yet) 
   
9 Was a sterile speculum performed?    
10 Was a visual assessment of the cervix documented?    
11 Was a ward Hb done?    
12 Was a new MSU sent for culture and sensitivity?    
13 Were clear nursing prescriptions given regarding routine observations as per protocol?    
14 Were there any contra-indications for conservative management?    
15 Was antibiotics prescribed as per protocol?    
16 Was adequate patient counselling documented?    
Items related to in-patient stay  Yes No Not indicated 
17 Was patient checked twice a day for signs of chorioamnionitis?    
18 Was a daily kick chart done?    
19 Were pad checks done daily?    
20 Was BMZ given correctly?    
21 Was antibiotics administered correctly?    
22 
Was tocolysis given when prescribed? 
(Only indicated with contractions within the first 48 
hours after admission) 
   
23 Was results of special investigations documented?    
Stellenbosch University  https://scholar.sun.ac.za
